We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

VScan Rapid Tests to Be Assembled in China

By Labmedica staff writers
Posted on 17 Aug 2004
An agreement with a government-owned facility in China will allow some assembly there of the VScan test kits of Medical Services International, Inc. (Edmonton, Canada), according to an announcement by the company.

The agreement covers the company's VScan HIV and VScan tuberculosis (TB) tests. The facility is a GMP (good manufacturing practice) certified facility with an excellent quality assurance program, states Medical Services International. Also, the facility has 26 existing distributors and 3,000 direct sales outlets. In addition, it supplies 100 hospitals with medical supplies, providing Medical Services with a good distribution network.

Medical Services International has recently announced it is about to begin testing of the VScan TB test in the United States. The test gives no false-positives (100% specificity) and during independent testing showed an accuracy of more than 90%. The results are obtained in 10 minutes, so treatment can begin right away.

The company said it looks forward to having a partner who is very familiar with the requirements necessary to market its products in China, and anticipates significant results from its partnership.




Related Links:
Medical Service International

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
17 Aug 2004  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
17 Aug 2004  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
17 Aug 2004  |   Industry